07.21.15
Avery Dennison has introduced a line of new syringe labeling products to its pharmaceutical portfolio. The portfolio extension features safe, compliant labelstock solutions, which are designed to meet manufacturers’ standards for syringe and tight mandrel pharmaceutical applications.
“According to the IMS Institute for Healthcare Informatics, the global pharmaceutical segment is projected to grow to more than $1 trillion by 2018, with focused growth in the oncology, diabetes, pain and autoimmune therapy areas,” says David Collins, marketing director, specialty, Avery Dennison Label and Packaging Materials, North America.
The new Avery Dennison syringe portfolio includes labeling solutions that offer low migration and high-performance adhesives on flexible paper and film facestocks. Products are sterilization-friendly and resistant to heat, steam and chemicals. Photoluminescent options are available to aid with missing label detection using ultraviolet light.
“Choosing the right label solution can help customers avoid costly failures at the packaging line,” adds Collins.
Adhesives used within the pharmaceutical industry must undergo comprehensive FDA testing to ensure they comply with toxicology requirements. If any adhesive changes are to occur, Avery Dennison notifies converters months in advance in order to make sure the new formulations are properly tested for compliance.
“According to the IMS Institute for Healthcare Informatics, the global pharmaceutical segment is projected to grow to more than $1 trillion by 2018, with focused growth in the oncology, diabetes, pain and autoimmune therapy areas,” says David Collins, marketing director, specialty, Avery Dennison Label and Packaging Materials, North America.
The new Avery Dennison syringe portfolio includes labeling solutions that offer low migration and high-performance adhesives on flexible paper and film facestocks. Products are sterilization-friendly and resistant to heat, steam and chemicals. Photoluminescent options are available to aid with missing label detection using ultraviolet light.
“Choosing the right label solution can help customers avoid costly failures at the packaging line,” adds Collins.
Adhesives used within the pharmaceutical industry must undergo comprehensive FDA testing to ensure they comply with toxicology requirements. If any adhesive changes are to occur, Avery Dennison notifies converters months in advance in order to make sure the new formulations are properly tested for compliance.